Literature DB >> 2701640

An overview on interleukin-1 as a therapeutic agent.

C A Dinarello1, R Neta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2701640     DOI： 10.1007/BF02171000

Source DB:  PubMed          Journal:  Biotherapy        ISSN： 0921-299X


× No keyword cloud information.
  3 in total

1.  The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate.

Authors:  T R Ulich; L R Watson; S M Yin; K Z Guo; P Wang; H Thang; J del Castillo
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

2.  Systemic treatment with murine recombinant interleukin-1 beta inhibits the growth and progression of malignant glioma in the rat.

Authors:  C D Rice; R E Merchant
Journal:  J Neurooncol       Date:  1992-05       Impact factor: 4.130

3.  The interleukin-1 receptor antagonist can either reduce or enhance the lethality of Klebsiella pneumoniae sepsis in newborn rats.

Authors:  J Mancilla; P García; C A Dinarello
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.